Insulin-Like Growth Factor
Search The Article
Categories
- All
- Analytical Testing
- Antioxidants
- Bone Density / Osteoporosis
- Cagrilintide
- Cellular Energy (Mitochondrial Function)
- Cerebrolysin
- Cognition
- Endotoxins
- Eye Research
- General Peptide Information
- Insulin-Like Growth Factor
- Metabolic Disease
- Repair Signaling
- Skin Regeneration
- Sterility
- Uncategorized
- Vasodilator
- Wound Healing
Everything on this website – articles and product details – is meant for learning and information purposes only. The products we sell are designed for lab testing only (studies done in test tubes or petri dishes, not in living things). These products are not medications, treatments, or cures for any illness. They haven’t been reviewed or approved by the FDA.
-
April 29th
-
Peptidology Research Faculty
CJC-1295/Ipamorelin Peptide: Synchronizing the Somatotropic Clock
CJC-1295/Ipamorelin is a research-grade blend that pairs a long-acting growth-hormone-releasing-hormone (GHRH) analogue, CJC-1295, with a selective growth-hormone secretagogue receptor (GHSR-1a) agonist, Ipamorelin. Individually, the two peptides engage complementary loci within the somatotropic axis—CJC-1295 mimics endogenous GHRH at the pituitary, while Ipamorelin allosterically activates the ghrelin receptor. Together, they have attracted attention as a tool for […]
-
April 4th
-
Peptidology Research Faculty
NA-931 Peptide: A Quadruple-Agonist Breakthrough in Obesity Research
Obesity is a complex metabolic condition affecting over 650 million adults worldwide, often accompanied by type 2 diabetes and other disorders. Traditional treatments, including diet, exercise, and even newer GLP-1 analog medications, have achieved significant weight loss but can come with limitations such as gastrointestinal side effects and unintended loss of lean muscle mass. This […]